IC-13 Anti-Angiogenesis in Modern Times

Course Organiser: U. Schmidt-Erfurth AUSTRIA

 

U. Schmidt-Erfurth AUSTRIA 
Brolucizumab: A novel player on the horizon

D. Martin USA 
How to choose the right anti-VEGF therapy in AMD

N. Waheed USA
Evaluating the therapeutic response of CNV by OCT-A

A. Loewenstein ISRAEL
A state-of-the-art in anti-VEGF in diabetic retinopathy

P. Dugel USA
Anti-angiopoetin: A new non-VEGF concept in AMD and DME

 

Discussion

End of course

Book your Course Ticket here and select ‘Add another registration package’

 

Back

Want to find out more about EURETINA activities?

Contact us
© EURETINA All rights reserved